Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rivers

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 11, 2016
Efficacy and Safety of OnabotulinumtoxinA Treatment of Forehead Lines: A Multicenter, Randomized, Dose-Ranging Controlled TrialNowell Solish, Jason K Rivers, Shannon Humphrey, et al.
JAMA|June 24, 2000
Broad-spectrum sunscreen use and the development of new nevi in white children: A randomized controlled trialR P Gallagher, J K Rivers, T K Lee, et al.
Journal of the American Academy of Dermatology|September 1, 1991
Melanocytic nevus density in Asian, Indo-Pakistani, and white children: the Vancouver Mole StudyR P Gallagher, J K Rivers, C P Yang, et al.
Journal of the American Academy of Dermatology|June 1, 1995
The eastern Australian childhood nevus study: prevalence of atypical nevi, congenital nevus-like nevi, and other pigmented lesionsJ K Rivers, R MacLennan, J W Kelly, et al.
Plastic and Reconstructive Surgery|August 13, 2025
Improvement of Lower Facial Shape After Treatment With OnabotulinumtoxinA: Secondary Results From a Phase 2 Dose Escalation StudySteven Liew, Jason K Rivers, Shannon Humphrey, et al.
Histopathology|April 1, 1991
Patients with thick melanomas surviving at least 10 years: histological, cytometric and HLA analysesJ K Rivers, S W McCarthy, H M Shaw, et al.
Cancer|March 1, 1990
Clinical characteristics of malignant melanomas developing in persons with dysplastic neviJ K Rivers, A W Kopf, A F Vinokur, et al.
The British Journal of Dermatology|November 1, 1990
The presence of autoantibody to recombinant lipocortin-I in patients with psoriasis and psoriatic arthritisJ K Rivers, M R Podgorski, N J Goulding, et al.
Cancer|January 15, 1989
Dysplastic nevi. Markers for increased risk for melanomaD S Rigel, J K Rivers, A W Kopf, et al.
The Journal of Dermatologic Surgery and Oncology|August 1, 1988
Skin types in dysplastic nevus syndromeA W Kopf, R J Goldman, J K Rivers, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 11, 2016
Efficacy and Safety of OnabotulinumtoxinA Treatment of Forehead Lines: A Multicenter, Randomized, Dose-Ranging Controlled TrialNowell Solish, Jason K Rivers, Shannon Humphrey, et al.
JAMA|June 24, 2000
Broad-spectrum sunscreen use and the development of new nevi in white children: A randomized controlled trialR P Gallagher, J K Rivers, T K Lee, et al.
Journal of the American Academy of Dermatology|September 1, 1991
Melanocytic nevus density in Asian, Indo-Pakistani, and white children: the Vancouver Mole StudyR P Gallagher, J K Rivers, C P Yang, et al.
Journal of the American Academy of Dermatology|June 1, 1995
The eastern Australian childhood nevus study: prevalence of atypical nevi, congenital nevus-like nevi, and other pigmented lesionsJ K Rivers, R MacLennan, J W Kelly, et al.
Plastic and Reconstructive Surgery|August 13, 2025
Improvement of Lower Facial Shape After Treatment With OnabotulinumtoxinA: Secondary Results From a Phase 2 Dose Escalation StudySteven Liew, Jason K Rivers, Shannon Humphrey, et al.
Histopathology|April 1, 1991
Patients with thick melanomas surviving at least 10 years: histological, cytometric and HLA analysesJ K Rivers, S W McCarthy, H M Shaw, et al.
Cancer|March 1, 1990
Clinical characteristics of malignant melanomas developing in persons with dysplastic neviJ K Rivers, A W Kopf, A F Vinokur, et al.
The British Journal of Dermatology|November 1, 1990
The presence of autoantibody to recombinant lipocortin-I in patients with psoriasis and psoriatic arthritisJ K Rivers, M R Podgorski, N J Goulding, et al.
Cancer|January 15, 1989
Dysplastic nevi. Markers for increased risk for melanomaD S Rigel, J K Rivers, A W Kopf, et al.
The Journal of Dermatologic Surgery and Oncology|August 1, 1988
Skin types in dysplastic nevus syndromeA W Kopf, R J Goldman, J K Rivers, et al.
Pageof 11